This Saturday's March for Science is trying hard to be a nonpartisan event, but some may not see it that way. » Read More
The new plan to repeal and replace Obamacare is an attempt to bridge the gap between the House Freedom Caucus and moderates. » Read More
The West Virginia attorney general says Mylan could be liable for more than the $465 million the company agreed to pay.
Anthem said sales of Obamacare plans have been disappointing to date, and the company could pull back its business in those plans in 2018.
The deal could include $8.5 billion in cash as well as future royalty payments for the embattled pharmaceutical company.
The Republican presidential nominee is hoping that stories about rising Obamacare rates will help him with voters next Tuesday.
Billionaire investor and Hillary Clinton-supporter Mark Cuban said that Donald Trump has no idea how Obamacare works.
Health care advocates are urging people to shop for 2017 coverage when the annual open enrollment period begins.
Valeant's former CEO and CFO are at the center of a U.S. criminal probe against the drugmaker over its ties to a specialty pharmacy.
Enrollment runs from Tuesday through Jan. 31. Most Americans must have some form of health coverage during 2017 or face a tax penalty.
The IBB fell nearly 11 percent this month and could be headed lower.
U.S. hospital staffing provider TeamHealth said on Monday it agreed to be acquired by Blackstone in a deal valued at about $6.1 billion.
Half of the people who buy health plans through government-run Obamacare marketplaces are cutting back on care to manage costs.
Last year the flu cost the economy billions of dollars. This season could be worse, since fewer people are opting for vaccinations.
The deal requires Mylan to pay $465 million to settle claims the company shortchange Medicaid on EpiPen rebates.
Most voters care more about issues other than health care when it comes to picking the next president.
Average deductibles for Obamacare bronze plans will top $6,000 for individuals for the first time next year.
Auvi-Q's return was announced as Mylan continues to be criticized for raising the price of lifesaving EpiPens more than 500 percent in recent years.
Median incomes have not kept pace with the inflation rate for job-based health insurance costs, straining family budgets.
For many, Theranos and Elizabeth Holmes represented a promise that disease could be caught sooner, NBC News reports.
Financial advisors warn that near-certain high medical costs should be a key line item in any investor's retirement plan.
Top-ranked analyst Irina Koffler of Mizuho Securities initiated shares of Mylan with a buy rating on Wednesday.
Get the best of CNBC in your inbox